N-((1S)-3-((3-EXO)-3-(3,5-BIS(1-METHYLETHYL)-4H-1,2,4-TRIAZOL-4-YL)-8-AZABICYCLO(3.2.1)OCT-8-YL)-1-PHENYLPROPYL)-4,4-DIFLUOROCYCLOHEXANECARBOXAMIDE
UNII EB25LBV6F8
Substance Identification & Data
This profile provides standardized clinical and technical data for N-((1s)-3-((3-exo)-3-(3,5-bis(1-methylethyl)-4h-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-4,4-difluorocyclohexanecarboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) EB25LBV6F8.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2414312-17-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C31H45F2N5O ABHJYQXHLQRRMM-XUJYPJAKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for N-((1s)-3-((3-exo)-3-(3,5-bis(1-methylethyl)-4h-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-4,4-difluorocyclohexanecarboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.